MAIA Biotechnology Files 8-K

Ticker: MAIA · Form: 8-K · Filed: Jul 17, 2025 · CIK: 1878313

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

MAIA Bio filed an 8-K on 7/17/25, but the details are missing here.

AI Summary

MAIA Biotechnology, Inc. filed an 8-K on July 17, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures within the provided text.

Why It Matters

This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, but the specific details of the events or financial information are not disclosed in this excerpt.

Risk Assessment

Risk Level: low — The filing is a standard procedural report without immediate financial or operational implications disclosed in the provided text.

Key Players & Entities

FAQ

What specific events are being reported in this 8-K filing by MAIA Biotechnology, Inc.?

The provided text states that the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not specify the nature of these events or the content of the financial statements.

When was the earliest event reported in this Form 8-K?

The earliest event reported is dated July 17, 2025.

What is the principal executive office address for MAIA Biotechnology, Inc.?

The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.

Under which state is MAIA Biotechnology, Inc. incorporated?

MAIA Biotechnology, Inc. is incorporated in Delaware.

What is the SEC file number for MAIA Biotechnology, Inc.?

The SEC file number for MAIA Biotechnology, Inc. is 001-41455.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing